Condition Lookup
Sub-Category:
Type 1 Diabetes Mellitus
Number of Conditions: 1
Autoimmune destruction of pancreatic beta cells (Type 1 Diabetes)
Specialty: Diabetes and Endocrinology
Category: Diabetes Mellitus and Related Disorders
Sub-category: Type 1 Diabetes Mellitus
Symptoms:
frequent urination (polyuria); excessive thirst (polydipsia); unintended weight loss; fatigue; blurred vision; slow wound healing; recurrent infections
Root Cause:
The immune system attacks and destroys insulin-producing beta cells in the pancreas, leading to a lack of insulin production and resul.ting in hyperglycemia.
How it's Diagnosed: videos
Diagnosed by hyperglycemia, autoantibodies (e.g., GAD, ICA), and low C-peptide levels.
Treatment:
Treated with insulin therapy and blood glucose monitoring.
Medications:
Insulin is the primary treatment, including long-acting (e.g., glargine , detemir ) and short-acting (e.g., lispro, aspart) insulin analogs. These are classified as hormone replacement therapies.
Prevalence:
How common the health condition is within a specific population.
Accounts for approximately 5–10% of all diabetes cases; often diagnosed in childhood but can occur at any age.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Family history of type 1 diabetes, presence of other autoimmune conditions, certain genetic markers (e.g., HLA-DR3, HLA-DR4), and environmental triggers (e.g., viral infections).
Prognosis:
The expected outcome or course of the condition over time.
Lifelong management with insulin therapy is required. With proper treatment, individuals can lead normal, healthy lives, although there is an increased risk of complications if poorly managed.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Diabetic ketoacidosis (DKA), chronic complications like retinopathy, nephropathy, neuropathy, and an increased risk of cardiovascular disease.